Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Tolerability of Sodium Oxybate in Fibromyalgia
NCT00803023Phase 3Completed
- Sponsor
- Jazz Pharmaceuticals plc
- Start
- Mar 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sodium oxybate in fibromyalgia (FM), sponsored by Jazz Pharmaceuticals plc. Started Mar 2010; status: completed.
02
Drugs
sodium oxybate
03
Conditions
fibromyalgia (FM)
Beyond the preview
Go deeper on NCT00803023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00803023.